Overview

A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma

Status:
Unknown status

Trial end date:
2020-10-01

Target enrollment:

Participant gender:

Summary

This is a multicenter, randomized, open-label, phase III trail comparing adjuvant chemoradiotherapy (Paclitaxel and carboplatin) to adjuvant radiotherapy in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal squamous cell carcinoma.

Phase:

Phase 3

Details

Lead Sponsor:

Zhejiang Cancer Hospital

Treatments:

Albumin-Bound Paclitaxel
Carboplatin
Paclitaxel